Yahoo India Web Search

Sign In

Search results

    • Biopharmaceutical company

      • Athira Pharma Inc (Athira Pharma) is a biopharmaceutical company that develops small molecules to treat neurodegenerative diseases and restore neuronal health.
      www.globaldata.com/company-profile/athira-pharma-inc/

      Athira Pharma Inc Company Profile - Overview - GlobalData

  2. People also ask

  3. www.athira.com › aboutAbout - Athira Pharma

    We are a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration. At Athira, we are committed to restoring, rebuilding and retaining connections.

    • Kevin Church

      Kevin entered a career in the life sciences industry in...

    • Science

      By clicking on the links below, you will leave Athira’s...

    • News

      Athira Pharma Presents Preclinical Data Demonstrating New...

    • Patients

      Athira aims to discover and develop important new...

    • Contact

      18706 North Creek Parkway Suite 104 Bothell, WA 98011. For...

    • Medical Affairs

      Athira Scientific Publications and Presentations....

    • Therapeutic Focus

      At Athira, We are Focused on Improving Neuronal Health by...

    • Investor Relations

      We are a late clinical-stage biopharmaceutical company...

  4. en.wikipedia.org › wiki › Athira_PharmaAthira Pharma - Wikipedia

    Athira Pharma is a late clinical stage American biopharmaceutical company developing small molecules to restore neuronal health and stop the neurodegeneration brought on by diseases such as Alzheimer's disease and Parkinson's disease. The company's lead candidate, ATH-1017, is in human studies for Alzheimer's disease as of 2021.

  5. investors.athira.com › news-releases › news-releaseAthira Pharma Reports Full Year 2023 Financial Results and ...

    Feb 22, 2024 · Athira Pharma, Inc., headquartered in the Seattle, Washington area, is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration.

  6. stockanalysis.com › stocks › athaAthira Pharma, Inc. (ATHA) Company Profile & Overview - Stock ...

    Sep 20, 2024 · Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.

  7. investors.athira.comInvestor Relations | Athira Pharma

    We are a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration. With our product candidates, we aim to provide rapid cognitive improvement and alter the course of neurological diseases with our novel mechanism of action.

  8. investors.athira.com › news-releases › news-releaseAthira Pharma Provides 2024 Clinical Pipeline Outlook and ...

    Jan 8, 2024 · BOTHELL, Wash., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today provided a clinical pipeline outlook and business update for 2024.

  9. finance.yahoo.com › news › athira-pharma-focusAthira Pharma to Focus on Advancement of ATH-1105 for the ...

    Sep 17, 2024 · BOTHELL, Wash., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to restore neuronal health ...